These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20697086)

  • 1. Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.
    Anderson JR; Barr FG; Hawkins DS; Parham DM; Skapek SX; Triche TJ
    J Clin Oncol; 2010 Oct; 28(29):e587-8; author reply e589-90. PubMed ID: 20697086
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation.
    Wexler LH; Ladanyi M
    J Clin Oncol; 2010 May; 28(13):2126-8. PubMed ID: 20351321
    [No Abstract]   [Full Text] [Related]  

  • 3. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
    Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
    J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar rhabdomyosarcoma masquerading as embryonal subtype: the value of modern molecular diagnostic testing.
    Eftekhari K; Chambers CB; Goldstein SM; Katowitz WR; Katowitz JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):e43-5. PubMed ID: 24608324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway].
    Orbach D
    Bull Cancer; 2014 Sep; 101(9):776-7. PubMed ID: 25295632
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features.
    La Starza R; Nofrini V; Pierini T; Pierini V; Zin A; Bisogno G; Cerri C; Caniglia M; Sidoni A; Ludwig K; Mecucci C
    Pediatr Blood Cancer; 2015 Dec; 62(12):2238-41. PubMed ID: 26179572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.
    Arnold MA; Anderson JR; Gastier-Foster JM; Barr FG; Skapek SX; Hawkins DS; Raney RB; Parham DM; Teot LA; Rudzinski ER; Walterhouse DO
    Pediatr Blood Cancer; 2016 Apr; 63(4):634-9. PubMed ID: 26756883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonal and alveolar rhabdomyosarcoma of parameningeal sites in adults: a report of 13 cases.
    Montone KT; Barr FG; Zhang PJ; Feldman MD; LiVolsi VA
    Int J Surg Pathol; 2009 Feb; 17(1):22-30. PubMed ID: 18945709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.
    Hingorani P; Missiaglia E; Shipley J; Anderson JR; Triche TJ; Delorenzi M; Gastier-Foster J; Wing M; Hawkins DS; Skapek SX
    Clin Cancer Res; 2015 Oct; 21(20):4733-9. PubMed ID: 26473193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Rudzinski ER; Teot LA; Anderson JR; Moore J; Bridge JA; Barr FG; Gastier-Foster JM; Skapek SX; Hawkins DS; Parham DM
    Am J Clin Pathol; 2013 Jul; 140(1):82-90. PubMed ID: 23765537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic potential of the chromosome translocation t(2;13) in rhabdomyosarcoma: a Pcr study of fresh-frozen and paraffin-embedded tumour samples.
    Reichmuth C; Markus MA; Hillemanns M; Atkinson MJ; Unni KK; Saretzki G; Höfler H
    J Pathol; 1996 Sep; 180(1):50-7. PubMed ID: 8943815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood rhabdomyosarcoma: new insight on biology and treatment.
    Huh WW; Skapek SX
    Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors.
    van den Broeke LT; Pendleton CD; Mackall C; Helman LJ; Berzofsky JA
    Cancer Res; 2006 Feb; 66(3):1818-23. PubMed ID: 16452243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.
    Gallego S; Llort A; Roma J; Sabado C; Gros L; de Toledo JS
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):356-62. PubMed ID: 16435141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of alveolar rhabdomyosarcoma in pleural fluid with immunocytochemistry on cell block and determination of PAX/FKHR fusion mRNA by reverse transcription-polymerase chain reaction.
    Sawangpanich R; Larbcharoensub N; Jinawath A; Pongtippan A; Anurathapan U; Hongeng S
    J Med Assoc Thai; 2011 Nov; 94(11):1394-8. PubMed ID: 22256481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma.
    Eguchi-Ishimae M; Tezuka M; Kokeguchi T; Nagai K; Moritani K; Yonezawa S; Tauchi H; Tokuda K; Ishida Y; Ishii E; Eguchi M
    Genes Chromosomes Cancer; 2019 Aug; 58(8):521-529. PubMed ID: 30739374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Strategy for Pediatric Paratesticular Rhabdomyosarcoma Based on Chimeric Gene Assessment.
    Unno R; Mizuno K; Ito Y; Etani T; Okada A; Kawai N; Yasui T; Saitoh S; Hayashi Y
    Urology; 2016 Sep; 95():187-9. PubMed ID: 27017905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Takayama J; Ohira M; Yokoyama R; Beppu Y; Takaue Y
    Pediatr Hematol Oncol; 2003; 20(3):201-10. PubMed ID: 12637216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan.
    Fasina O
    Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.